FindTrial
Sign In

Follicular Fluid Anti-Mullerian Hormone (AMH) levels and Assisted Reproductive Technology (ART) outcomes.

: Anti-Mullerian Hormone (AMH) Levels In Follicular Fluid As A Predictor Of Assisted Reproductive Technology (ART) Outcomes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/05/019433
Enrollment
100
Registered
2019-05-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: N979- Female infertility, unspecified

Interventions

None listed

Sponsors

Nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women between 23-40 years of age undergoing ART includes In vitro insemination (IVI) and intracytoplasmic sperm injection (ICSI)

Exclusion criteria

Exclusion criteria: Diminished ovarian reserve-defined as Serum AMH levels Stage III-IV endometriosis Intracytoplasmic sperm injection done using surgically retrieved spermatozoa Cycles where no oocytes retrieved on the day of aspiration.

Design outcomes

Primary

MeasureTime frame
Clinical pregnancy rate per embryo transferTimepoint: April 2020—

Secondary

MeasureTime frame
Collected oocyte quality Fertilization rate Embryo development rate Implantation rate Correlation between follicular fluid levels and serum AMH levels pregnant and non-pregnant womenTimepoint: April 2020—

Countries

India

Contacts

Public ContactMr Muthu Kumar K

Christian Medical College and Hospital

muthukumar.karthikeyan957@gmail.com04162283301

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026